NO990948L - Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner - Google Patents

Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner

Info

Publication number
NO990948L
NO990948L NO990948A NO990948A NO990948L NO 990948 L NO990948 L NO 990948L NO 990948 A NO990948 A NO 990948A NO 990948 A NO990948 A NO 990948A NO 990948 L NO990948 L NO 990948L
Authority
NO
Norway
Prior art keywords
htlv
medication
infections
preparation
treatment
Prior art date
Application number
NO990948A
Other languages
English (en)
Other versions
NO990948D0 (no
Inventor
Michael R Jirousek
Douglas K Ways
Lawrence E Stramm
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO990948D0 publication Critical patent/NO990948D0/no
Publication of NO990948L publication Critical patent/NO990948L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Fremgangsmåte for behandling av infeksjon med human T-cellelymfotroft virus, type l, under anvendelse av en isozymselektiv PKC-inhibitor, særlig ved å anvende den isozymselektive PKC- inhibitor (S)-3,4-[N/N1-l,l'-((211- etoksy)-3' ' '(O)-4 ' ' '-(N,N-dimetyl- amino)-butan)-bis-(3,3'-indolyl)]-l(H)- pyrrol-2,5-dion-hydrokloridsalt.
NO990948A 1996-08-30 1999-02-26 Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner NO990948L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2493896P 1996-08-30 1996-08-30
US08/917,517 US5962446A (en) 1996-08-30 1997-08-26 Therapetutic treatment for human T cell lymphotrophic virus type 1 infection
PCT/US1997/015524 WO1998008508A1 (en) 1996-08-30 1997-08-28 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections

Publications (2)

Publication Number Publication Date
NO990948D0 NO990948D0 (no) 1999-02-26
NO990948L true NO990948L (no) 1999-04-28

Family

ID=26699066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990948A NO990948L (no) 1996-08-30 1999-02-26 Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner

Country Status (14)

Country Link
US (1) US5962446A (no)
EP (1) EP0830861A1 (no)
JP (1) JP2002514176A (no)
KR (1) KR20000035864A (no)
CN (1) CN1231608A (no)
AU (1) AU4179397A (no)
BR (1) BR9711366A (no)
CA (1) CA2263161A1 (no)
EA (1) EA199900243A1 (no)
IL (1) IL128493A0 (no)
NO (1) NO990948L (no)
PL (1) PL331759A1 (no)
TR (1) TR199900905T2 (no)
WO (1) WO1998008508A1 (no)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US5063238A (en) * 1989-11-13 1991-11-05 Merrell Dow Pharmaceuticals Inc. Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
HUT69164A (en) * 1993-12-07 1995-08-28 Lilly Co Eli Improved process for producing bis-indolyl-maleimide derivatives
SG63570A1 (en) * 1993-12-07 1999-03-30 Lilly Co Eli Protein kinase c inhibitors
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors

Also Published As

Publication number Publication date
AU4179397A (en) 1998-03-19
TR199900905T2 (xx) 1999-07-21
WO1998008508A1 (en) 1998-03-05
US5962446A (en) 1999-10-05
CA2263161A1 (en) 1998-03-05
BR9711366A (pt) 1999-08-17
CN1231608A (zh) 1999-10-13
EA199900243A1 (ru) 1999-10-28
PL331759A1 (en) 1999-08-02
KR20000035864A (ko) 2000-06-26
JP2002514176A (ja) 2002-05-14
IL128493A0 (en) 2000-01-31
NO990948D0 (no) 1999-02-26
EP0830861A1 (en) 1998-03-25

Similar Documents

Publication Publication Date Title
EA199800971A1 (ru) Способ лечения новообразований, вкючающий применение ингибиторов протеиназы с
NO985066L (no) Terapeutisk behandling for VEGF-relaterte sykdommer
EA199800970A1 (ru) Терапевтическое лечение глазных заболеваний, связанных с фактором роста сосудистого эндотелия
CA2339218A1 (en) Methods and compositions for increasing insulin sensitivity
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
DE69735134D1 (de) Therapeutische behandlung von kardiovaskularen krankheiten
NO995231L (no) Terapeutisk behandling av hudlidelser
HK1050011A1 (zh) 用levovirintm治療病毒性感染
NO984920D0 (no) Sammensetninger omfattende en nitroneforbindelse for anvendelse ved behandling av okulµr inflammasjon
NO990949L (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
NO990948L (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner
NZ334609A (en) Use of inhibitors of the beta isozyme of protein kinase C for treatment of sexual dysfunctions in mammals
EP0940141A3 (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection
EP0940142A3 (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
NO990947L (no) Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon
EP0940143A3 (en) Use of PKC-inhibitors for the manufacture of a medicament for the treatment of asthma
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool
WO1999026609A3 (en) Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
BR0016654A (pt) Composto, método para o tratamento da dor, e, composição farmacêutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application